Glassman Wealth Services’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-121
Closed -$1.45K 493
2023
Q4
$1.45K Buy
+121
New +$991 ﹤0.01% 1438
2023
Q2
Sell
-17
Closed -$155 1922
2023
Q1
$155 Buy
+17
New +$217 ﹤0.01% 1844
2022
Q3
Sell
-7
Closed 1689
2022
Q2
$0 Buy
+7
New +$194 ﹤0.01% 1700
2021
Q1
Sell
-10
Closed -$1K 1411
2020
Q4
$1K Buy
+10
New +$579 ﹤0.01% 1172

Other funds holding CDNA

Glassman Wealth Services's CDNA Position: Q1 2024 in Review

Glassman Wealth Services sold out of CareDx (CDNA) in Q1 2024, closing a stake of 121 shares — an estimated $1.45K sold.

Glassman Wealth Services first reported a position in CDNA in Q4 2020 and held it in 4 quarters. The position peaked at $1.45K in Q4 2023. 147 funds tracked by Wall St. Rank hold CDNA as of Q1 2024.

  • Glassman Wealth Services reported no remaining CareDx position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 121 CareDx shares in Q1 2024, an estimated $1.45K.
  • Glassman Wealth Services first reported a position in CareDx in Q4 2020 and held it in 4 quarters.
  • Glassman Wealth Services's CareDx position peaked at $1.45K in Q4 2023.
  • 147 funds tracked by Wall St. Rank held CareDx as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.